CN102919863B - 一种梅花鹿肝/心粉或颗粒、制备方法及应用 - Google Patents
一种梅花鹿肝/心粉或颗粒、制备方法及应用 Download PDFInfo
- Publication number
- CN102919863B CN102919863B CN2012104281857A CN201210428185A CN102919863B CN 102919863 B CN102919863 B CN 102919863B CN 2012104281857 A CN2012104281857 A CN 2012104281857A CN 201210428185 A CN201210428185 A CN 201210428185A CN 102919863 B CN102919863 B CN 102919863B
- Authority
- CN
- China
- Prior art keywords
- heart
- liver
- deer liver
- spotted deer
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 111
- 239000000843 powder Substances 0.000 title claims abstract description 44
- 239000002245 particle Substances 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 241000283007 Cervus nippon Species 0.000 title abstract 9
- 241001416181 Axis axis Species 0.000 claims description 93
- 239000000725 suspension Substances 0.000 claims description 36
- 241000282994 Cervidae Species 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000012153 distilled water Substances 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 230000002572 peristaltic effect Effects 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 11
- 230000003179 granulation Effects 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 235000013336 milk Nutrition 0.000 claims description 9
- 239000008267 milk Substances 0.000 claims description 9
- 210000004080 milk Anatomy 0.000 claims description 9
- 229920002472 Starch Polymers 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 235000011950 custard Nutrition 0.000 claims description 6
- 108090000145 Bacillolysin Proteins 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 102000035092 Neutral proteases Human genes 0.000 claims description 5
- 108091005507 Neutral proteases Proteins 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 230000002797 proteolythic effect Effects 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 244000240602 cacao Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 14
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 13
- 229920001184 polypeptide Polymers 0.000 abstract description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract description 5
- 235000003704 aspartic acid Nutrition 0.000 abstract description 5
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 239000003797 essential amino acid Substances 0.000 abstract description 4
- 235000020776 essential amino acid Nutrition 0.000 abstract description 4
- 239000004471 Glycine Substances 0.000 abstract description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 229960000310 isoleucine Drugs 0.000 abstract description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- -1 praline Chemical compound 0.000 abstract description 2
- 230000002107 myocardial effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 26
- 239000007788 liquid Substances 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 239000000523 sample Substances 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 11
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000012467 final product Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- 240000001417 Vigna umbellata Species 0.000 description 5
- 235000011453 Vigna umbellata Nutrition 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000000451 gelidium spp. gum Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000011122 softwood Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000005477 standard model Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 108010070915 orgotein Proteins 0.000 description 1
- 229960004534 orgotein Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000013595 supernatant sample Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUGDLVFMIQZYPA-UHFFFAOYSA-N tetracopper;tetrazinc Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2] TUGDLVFMIQZYPA-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
时间(分钟) | 流速(ml/min) | A液(%) | B液(%) |
起始 | 0.7 | 99.9 | 0.1 |
0.54 | 0.7 | 99.9 | 0.1 |
5.74 | 0.7 | 90.9 | 9.1 |
7.74 | 0.7 | 78.8 | 21.2 |
8.04 | 0.7 | 40.4 | 59.6 |
8.64 | 0.7 | 40.4 | 59.6 |
8.73 | 0.7 | 99.9 | 0.1 |
9.5 | 0.7 | 99.9 | 0.1 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012104281857A CN102919863B (zh) | 2012-10-31 | 2012-10-31 | 一种梅花鹿肝/心粉或颗粒、制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012104281857A CN102919863B (zh) | 2012-10-31 | 2012-10-31 | 一种梅花鹿肝/心粉或颗粒、制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102919863A CN102919863A (zh) | 2013-02-13 |
CN102919863B true CN102919863B (zh) | 2013-12-04 |
Family
ID=47634908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012104281857A Active CN102919863B (zh) | 2012-10-31 | 2012-10-31 | 一种梅花鹿肝/心粉或颗粒、制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102919863B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105146670B (zh) * | 2015-10-21 | 2017-11-10 | 中国科学院兰州化学物理研究所 | 一种驼血多肽泡腾片及其制备方法 |
CN105456291A (zh) * | 2015-12-31 | 2016-04-06 | 甘肃普尔康药业有限公司 | 一种肝浸膏规模化生产工艺 |
JP7167480B2 (ja) * | 2017-10-20 | 2022-11-09 | 大正製薬株式会社 | 経口液体組成物 |
CN110452948B (zh) * | 2019-09-12 | 2021-06-15 | 北华大学 | 鹿心蛋白水解物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1543987A (zh) * | 2003-11-18 | 2004-11-10 | 吉林大学 | 一种利用梅花鹿胎制备活性肽-鹿胎素的方法及应用 |
CN1552892A (zh) * | 2003-12-19 | 2004-12-08 | 吉林大学 | 复合蛋白酶催化制备生理活性鹿肽及鹿肽产品的应用 |
CN102669669A (zh) * | 2012-05-30 | 2012-09-19 | 吉林大学 | 一种鹿脾提取物制剂及其制备方法 |
-
2012
- 2012-10-31 CN CN2012104281857A patent/CN102919863B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1543987A (zh) * | 2003-11-18 | 2004-11-10 | 吉林大学 | 一种利用梅花鹿胎制备活性肽-鹿胎素的方法及应用 |
CN1552892A (zh) * | 2003-12-19 | 2004-12-08 | 吉林大学 | 复合蛋白酶催化制备生理活性鹿肽及鹿肽产品的应用 |
CN102669669A (zh) * | 2012-05-30 | 2012-09-19 | 吉林大学 | 一种鹿脾提取物制剂及其制备方法 |
Non-Patent Citations (4)
Title |
---|
东北梅花鹿药用价值新探;张焱等;《吉林中医药》;20120229;第32卷(第2期);第178-180页 * |
喷雾干燥技术在中药领域中的应用及进展;蔡薇等;《沈阳药科大学学报》;20060930;第23卷(第9期);第613-616页 * |
张焱等.东北梅花鹿药用价值新探.《吉林中医药》.2012,第32卷(第2期),第178-180页. |
蔡薇等.喷雾干燥技术在中药领域中的应用及进展.《沈阳药科大学学报》.2006,第23卷(第9期),第613-616页. |
Also Published As
Publication number | Publication date |
---|---|
CN102919863A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103005246B (zh) | 一种含龟甲胶原蛋白肽的龟苓膏及其制备工艺 | |
CN103385442B (zh) | 保健文蛤调味粉及其制备方法 | |
CN102696767B (zh) | 一种综合利用核桃仁生产低脂核桃乳、活性肽、蛋白粉的深加工方法 | |
CN104432388B (zh) | 文冠果肽营养品及其制备方法 | |
CN102578363B (zh) | 一种用禽皮制备小分子胶原蛋白多肽粉的方法及其在果汁饮品中的应用 | |
CN104323065B (zh) | 一种葛仙米果冻及制备方法 | |
CN105639014B (zh) | 一种多肽饮料及其制备方法 | |
CN103876146A (zh) | 一种林蛙油多肽含片及其制备方法 | |
CN102919863B (zh) | 一种梅花鹿肝/心粉或颗粒、制备方法及应用 | |
CN102258211B (zh) | 大马士革玫瑰悬浮饮料的制备方法 | |
CN101433328B (zh) | 鲜猴头菇全质营养粉的生产方法 | |
CN103876163A (zh) | 一种林蛙肉复合蛋白粉及其制备方法 | |
CN106666396A (zh) | 一种盐地碱蓬复合营养面条及其制备方法 | |
CN103976205B (zh) | 一种改善内分泌的果冻及其制备方法 | |
CN106858510A (zh) | 一种功能性竹荪酱油复合调味料及其制备方法 | |
CN105341238A (zh) | 一种小球藻多肽茶及其制作方法 | |
CN101897359B (zh) | 一种太子参调味乳及其制备方法 | |
CN109418883A (zh) | 一种茶树菇鸡精的制作方法 | |
CN106260497A (zh) | 一种大鲵滋补蛋白粉生产技术 | |
CN102599406A (zh) | 一种二元复合多肽咀嚼片的生产工艺 | |
CN112442522A (zh) | 一种秋葵肽的制备方法及制备的秋葵肽和应用 | |
CN104106680A (zh) | 一种速溶蜂蜜奶茶粉及其加工方法 | |
CN103355664B (zh) | 一种含大鲵骨的胶囊及其制备方法 | |
CN106490297A (zh) | 一种抗疲劳能量棒及其制备方法 | |
CN108522839A (zh) | 一种增强山羊免疫力的发酵饲料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191205 Address after: Room 501, 5th floor, 3rd floor, 188 West South Fourth Ring Road, Fengtai District, Beijing 100070 Patentee after: BEIJING ZHONGJING FENGCHUANG TECHNOLOGY Co.,Ltd. Address before: 130012 Changchun Qianjin Street, Jilin, No. 2699 Patentee before: Jilin University |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210104 Address after: 135099 No.1, building B, Laodong Jiayuan, Meihekou City, Tonghua City, Jilin Province Patentee after: Baizhi Health Technology (China) Co.,Ltd. Address before: 100070 Room 501, 5th floor, building 3, area 3, 188 South 4th Ring Road West, Fengtai District, Beijing Patentee before: BEIJING ZHONGJING FENGCHUANG TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211210 Address after: 135000 No. 3399, Nanhuan East Road, Meihekou City, Tonghua City, Jilin Province Patentee after: Naian Pharmaceutical (China) Co.,Ltd. Address before: 135099 No.1, building B, Laodong Jiayuan, Meihekou City, Tonghua City, Jilin Province Patentee before: Baizhi Health Technology (China) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 135000 No. 3399, Nanhuan East Road, Meihekou City, Tonghua City, Jilin Province Patentee after: Naian Brewing (China) Co.,Ltd. Country or region after: China Address before: 135000 No. 3399, Nanhuan East Road, Meihekou City, Tonghua City, Jilin Province Patentee before: Naian Pharmaceutical (China) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |